Navigation Links
Glypican-3 gene function in regulating body size helps inform novel cancer treatments
Date:5/12/2008

Toronto (May 13, 2008) - In a leading study that has implications for the development of novel therapies for a number of breast, lung and ovarian cancers that have lost the expression of a gene called glypican-3 (GPC3), Sunnybrook researchers have discovered how the loss of the GPC3 gene induces overgrowth through certain growth factors such as Sonic Hedgehog which stimulate cancer growth.

Published today in Developmental Cell, the study examines the molecular mechanism by which lack of functional GPC3 causes overgrowth in the Simpson-Golabi-Behmel syndrome (SGBS), a rare disorder that predisposes to cancers.

This vital new finding at the molecular level opens doors for the development of novel treatments to inhibit overgrowth activity to benefit SGBS patients and the many breast, lung and ovarian cancer patients linked to loss of GPC3, says Dr. Jorge Filmus, senior scientist, Division of Molecular and Cellular Biology, Sunnybrook Research Institute, and the studys lead investigator. Early clinical trials presented at the last annual meeting of the American Association for Cancer Research in which cancer patients are being treated using Hedgehog-inhibitor drugs show promise.

GPC3 or glypican-3 is one of six genes of the glypican family. Glypicans are expressed predominantly during development in a stage and tissue specific manner suggesting they play a role in cell growth and in establishing the shape of tissues and organs.


'/>"/>

Contact: Natalie Chung-Sayers
natalie.chung-sayers@sunnybrook.ca
416-480-4040
Sunnybrook Health Sciences Centre
Source:Eurekalert

Page: 1

Related biology news :

1. RevGenUK, a single-stop shop for use in functional genomics
2. Magnet Lab researchers make observing cell functions easier
3. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia
4. Mass. General study shows how exercise changes structure and function of heart
5. Vitamin D in brain function
6. New study shows that fetal cells to treat Parkinsons disease may not function long term
7. Veterinary college researchers explore function of biofilm in bovine respiratory disease
8. Biologists at UC San Diego identify key protein in cells self-eating function
9. Workman Lab characterizes novel regulator of chromosome function
10. MIT: Culture influences brain function
11. Xie Lab characterizes niche control of stem cell function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:6/27/2016)... June 27, 2016 Research and Markets has ... 2016-2020" report to their offering. ... America to grow at a CAGR of 12.28% during ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016 Neogen Corporation (NASDAQ: ... Dr. Dan Kephart as its chief science ... will assume his responsibilities at Neogen effective Jan. 1. ... director for the agribusiness unit of Thermo Fisher Scientific, ... at Life Technologies. His extensive industry experience also includes ...
(Date:12/7/2016)...  Nordion, a standalone business of Sterigenics International, ... award by the United States Department of Energy,s ... Phase II cooperative agreement funding to GA to ... of Missouri Research Reactor Center (MURR ® ). ... of a new, reliable supply of molybdenum 99 ...
(Date:12/7/2016)... ROCHESTER, Minn. , Dec. 7, 2016  Vyriad ... McQuinn to the company,s Board of Directors. ... board as we build our business and develop our ... for cancer therapy," said Stephen Russell , MD, ... Mary Agnes , share our vision and passion for ...
(Date:12/7/2016)... and ANN ARBOR, Mich. ... held biopharmaceutical company developing breakthrough immune modulatory medicines, announced ... of the Company,s lead therapeutic candidate, LYC-30937- E nteric ... often a debilitating skin disease that is estimated to ... the United States , with approximately 1.5 - ...
Breaking Biology Technology: